I was out @ 2.4 too, hit dougle top 2.6 (2.7 on 14 & 15 May last year. I think it will retrace soon. Chart shows overbought. Good luck to holders.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%